| Agenda at a Glance|
Full Day Symposium:
CREATING WIN-WIN SPONSOR, SITE,
INVESTIGATOR RELATIONSHIPS... |
...or Two Half-Day Workshops
| | 9:15 | Opening Remarks from the Symposium Chairperson | | 9:30 | Building an Effective Relationship Management Structure with Your Sites
Sanofi Pasteur | | 10:15 | Becoming a Sponsor of Choice: How to Improve Sponsor/Investigator Relationship
sanofi-aventis, U.S., Inc. | | 11:15 | Morning Networking Break | | 11:30 | Establishing and Utilizing Benchmarks to Gauge Site
Performance & Improve the Conduct of Clinical Trials
National Institutes of Health (NIH), Phidisa Project
South Africa | | 12:30 | Luncheon for CTC Attendees | | 1:30 | Creating True Sponsor-Site Partnerships
Pfizer Global Research & Development | | 2:15 | “In The News.” | | 3:00 | Afternoon Networking Break | | 3:30 | The Site as the Client
MCSI, Research Across America |
| | AM Workshop | (B2): Strategic Outsourcing Partnerships & Alliance Management
Otsuka Pharmaceuticals, AstraZeneca |
| PM Workshop | (B3): Clinical Technology & Data Management
Pfizer, Bayer Healthcare |
| 5:00.... End of Pre-Conference Day | |
| 8:45 | Two Part Keynote: Can the Current R&D Business Model Survive? Learning from the Golden Age of Pharma
Merck & Co, Centocor R&D, Eli Lilly & Co, AstraZeneca | | 10:45 | Morning Networking Break & Book Signing with Roy Vagelos
“Medicine, Science andMerck" and "The Moral Corporation, Merck Experiences" |
| | 11:15 | Special FDA Address: Critical Path Initiative Update
US Food & Drug Administration (FDA) | | 12:00 | Leaders Unite to Re-Think the Conduct of U.S. Based Clinical Trials: Clinical Trials Transformation Initiative Executive Committee Update
Gemin X, Johnson & Johnson, Duke University Medical Center |
| 1:00.... Luncheon for CTC Attendees |
KNOW WHERE YOU’RE GOING:
Set a Business Strategy to Ensure Peak Sales | PARTNER FOR SUCCESS:
Maximize Stakeholder Relationships | DO MORE WITH LESS:
Implement Metrics for Increased Productivity | 2:00 Developing a Business Case for Clinical
Improvements and Total Drug Valuation: Does Cost Impact Value Creation
Merck
| 2:00 Track Keynote: How Payer Perspectives Might Shape the Future of Drug Development Strategies:
Johnson & Johnson Health Care Systems, Pfizer
Takeda Pharmaceuticals North America, The Regence Group
| 2:00 Integrating a Metrics-Driven Approach to Subject Enrollment to Optimize Site Productivity
Inclinix, Inc.
| 2:45 Bridging the Gap Between Business & Clinical Development:
Shire Pharmaceuticals
| 2:45 Alliance Management: An Opportunity for Turn Key Project Management
MDS Pharma Services
| 2:45 What Can We Learn from the Small Pharma/Biotech Model of Clinical Development?
Genentech, Vifor Pharma, Otsuka
| 3:30 Afternoon Networking Break | 4:00 Expediting Trial Enrollment through Predictive Modeling
Acurian, Inc.
| 4:00 Leverage Offshore Capabilities, Align your Strategy, and Maintain a Successful Global Partnership
Johnson & Johnson, NPS,Wyeth, Abbot
| 4:00 A Systematic Approach to Investigator Contracting and Grant Payment Management
Clinical Financial Services
| 4:45 How Can I Expedite Go/No Go Decisions in Clinical Development
Pfizer | 4:45 Shortlisting and Assessing Vendors: Setting up for Success
MedNet Solutions, Inc. | 4:45 Maximizing Internal Resources on External Projects: to Drive Efficient and Effective Delivery
AstraZeneca Pharmaceuticals | 5:30 Cocktail Reception |
|
| 8:15 | Welcome & Opening Remarks from the Conference Chairperson | | 8:30 | Are M&A’s the New R&D? How Pharma/Biotech R&D Collaboration Is Driving Pipeline Innovation
Merck Serono International, Pfizer Global R&D, Bristol-Myers Squibb | | 9:30 | An Invitation: Together We Can Develop Medicines for Everyone Institute for One World Health |
| | 9:45 | Creating a Mission-Driven Organization: Communication, Change Management & Keeping the Patient at the Heart of the Business
Children’s Hospital of Philadelphia (CHOP) | | 10:30 | Morning Networking Break & Collaborative “Giving Back” Activity | | 11:30 | The Keys to Clinical Operations Success: Optimizing the Process by Focusing on The People First
sanofi-aventis, Purdue Pharma, Wyeth Pharmaceuticals, Merck & Co, Campbell Alliance |
|
SLASH TIME TO APPROVALS:
Design your Trial to Increase Speed to Market | LOOK TO THE FUTURE:
Thrive in the New Environment | 1:30 How Can you Fully Enroll a Trial in One Day? Overcoming Patient Recruitment Bottlenecks
Merck & Co, sanofi-aventis, Bristol-Myers Squibb , Eli Lilly & Co
| 1:30 Track Keynote: Where Will we Find the Next Therapeutic Area Breakthrough and How Will it Impact your Clinical Trials
GlaxoSmithKline, Wyeth, AstraZeneca, Schering-Plough | 2:15 Coming Soon- Check Back for Updates
Pharmanet
| 2:15 Where Will we Find the Next Big Global Site? Beyond China and India
Pfizer India, Sanofi-Aventis, GlaxoSmithKline | 3:00 How Can I Design a Trial to Ensure It’s Positioned for Faster Regulatory Approval
Amgen,Merck
| 3:00 Enrolling “Problem” Protocols: How to Rescue Your Study
BBK Worldwide
| | 3:45 “In The News.” | 3:45 How Social Media will Be A Key Element to Pharma’s Ability to Compete and Succeed in the Future
Eli Lilly & Co |
|